SCHEMBL13986010

SCHEMBL13986010

CCc1ccc(-c2ccc(C(=O)OC(C)C)c(CN(C)C3CC3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.40
HRH4 Q9H3N8 1/20 0.40
HSD17B1 P14061 1/20 0.39
MCHR1 Q99705 6/20 0.38
CYP2D6 P10635 4/20 0.38
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CA14 Q9ULX7 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SRD5A2 P31213 1/20 0.35
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
GPR119 Q8TDV5 1/20 0.33
CYP4F2 P78329 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13613898 0.90 RXRA (0.43) HRH3HRH4CA12CA1CA2
SCHEMBL13986027 0.89 FASN (0.39) HRH3HRH4HSD17B1CA12CA1
SCHEMBL13986012 0.88 HTR2A (0.37) HSD17B1CA12CA1CA2CA7
SCHEMBL13613881 0.86 PTGS2 (0.43) CA12CA1CA2CA7CA9
SCHEMBL14524808 0.84 PDCD1 (0.39) HRH3HRH4HSD17B1MCHR1CA12
SCHEMBL4513926 0.81 NOS3 (0.44) CYP2D6CA12CA1CA2CA7
SCHEMBL13613899 0.81 NR1H4 (0.36) CA12CA1CA2CA7CA9
SCHEMBL4511652 0.78 CA12 (0.37) CA12CA1CA2CA7CA9
SCHEMBL4527243 0.77 FFAR1 (0.40) CA12CA1CA2CA7CA9
SCHEMBL4518329 0.75 ACACB (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7468391-B2 Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B ALLERGAN, INC. (US) 2008-12-23 US disclosed